NeuroKaire Cleared in 49 of 50 States, So Physicians Can See Which Antidepressants Best Fit Each Patient's Biology
The Company's Breakthrough Test Evaluates How a Wide Panel of Antidepressants Affect Each Patient's Brain, Supporting Smarter Prescribing Decisions KEARNY, NJ, UNITED STATES, March 26, 2026 /EINPresswire.com/ -- NeuroKaire, a leader in …